Skip to main content

Thomas James Polascik, MD

Director, Urologic Oncology Fellowship
Professor of Surgery
Office: Room 1080 Yellow Zone, Duke South DUMC, Durham, NC 27710
Campus Mail: DUMC Box 2804 Med Ctr, DUMC, Durham, NC 27710

Prostate cancer imaging
Focal therapy of prostate cancer
Prostate cancer outcomes
Kidney cancer outcomes
Minimally invasive surgery
Nerve sparing cryotherapy

Education and Training

  • Fellowship, Urologic Oncology, Johns Hopkins University, 1997 - 1998
  • Assistant Chief of Service, Urology, Johns Hopkins University, 1997 - 1997
  • Chief Resident, Urology, Johns Hopkins University, 1996 - 1997
  • Resident, Urology, Johns Hopkins University, 1993 - 1996
  • Assistant Resident in General Surgery, Surgery, Johns Hopkins University, 1992 - 1993
  • Intern in General Surgery, Surgery, Johns Hopkins University, 1991 - 1992
  • M.D., The University of Chicago, 1991

In the News

Publications

Arcot, Rohith, Sitharthan Sekar, Srinath Kotamarti, Madison Krischak, Zoe D. Michael, Wen-Chi Foo, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.” Abdom Radiol (Ny), June 8, 2022. https://doi.org/10.1007/s00261-022-03562-w.

Full Text

Kotamarti, Srinath, Zoe Michael, David Silver, Ervin Teper, Alireza Aminsharifi, Thomas J. Polascik, and Ariel Schulman. “Device-related complications during renal cryoablation: insights from the Manufacturer and User Facility Device Experience (MAUDE) database.” Urol Oncol 40, no. 5 (May 2022): 199.e9-199.e14. https://doi.org/10.1016/j.urolonc.2022.03.002.

Full Text

Bakavicius, Arnas, Giancarlo Marra, Petr Macek, Cary Robertson, Andre L. Abreu, Arvin K. George, Bernard Malavaud, et al. “Available evidence on HIFU for focal treatment of prostate cancer: a systematic review.” Int Braz J Urol 48, no. 2 (March 2022): 263–74. https://doi.org/10.1590/S1677-5538.IBJU.2021.0091.

Full Text

Orabi, Hazem, Lauren Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, et al. “Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry.” Eur Urol Open Sci 37 (March 2022): 106–12. https://doi.org/10.1016/j.euros.2022.01.003.

Full Text

Owens, Jake L., Elena Beketova, Sheng Liu, Qi Shen, Jogendra Singh Pawar, Andrew M. Asberry, Jie Yang, et al. “Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.” Mol Cancer Ther 21, no. 3 (March 1, 2022): 448–59. https://doi.org/10.1158/1535-7163.MCT-21-0103.

Full Text

Berger, Miles, Jeffrey N. Browndyke, Mary Cooter Wright, Chloe Nobuhara, Melody Reese, Leah Acker, W Michael Bullock, et al. “Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers.” Ann Clin Transl Neurol 9, no. 2 (February 2022): 155–70. https://doi.org/10.1002/acn3.51499.

Full Text

Kotamarti, Srinath, Arvin George, Alex Zhu, and Thomas J. Polascik. “Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for the Detection of Prostate Cancer.” Urology, January 15, 2022. https://doi.org/10.1016/j.urology.2022.01.005.

Full Text

Osada, Takuya, Erika J. Crosby, Kensuke Kaneko, Joshua C. Snyder, Joshua D. Ginzel, Chaitanya R. Acharya, Xiao-Yi Yang, et al. “HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.” Mol Cancer Ther 21, no. 1 (January 2022): 217–26. https://doi.org/10.1158/1535-7163.MCT-21-0334.

Full Text

Pages